Volume 75, Issue 9 pp. 803-806

Clinical outcomes of deep atypical lipomas (well-differentiated lipoma-like liposarcomas) of the extremities

Scott M. M. Sommerville

Scott M. M. Sommerville

* Consultant Orthopaedic Surgeon, The Wesley Hospital, Brisbane, Australia, † Consultant Orthopaedic Surgeon, The Edinburgh Royal Infirmary, Edinburgh, Scotland, ‡ Orthopaedic Registrar, § Consultant Musculoskeletal Pathologist, The Royal Orthopaedic Hospital and ¶Consultant Orthopaedic Oncologist, The Royal Orthopaedic Hospital Oncology Service, Birmingham, United Kingdom

Search for more papers by this author
James T. Patton

James T. Patton

* Consultant Orthopaedic Surgeon, The Wesley Hospital, Brisbane, Australia, † Consultant Orthopaedic Surgeon, The Edinburgh Royal Infirmary, Edinburgh, Scotland, ‡ Orthopaedic Registrar, § Consultant Musculoskeletal Pathologist, The Royal Orthopaedic Hospital and ¶Consultant Orthopaedic Oncologist, The Royal Orthopaedic Hospital Oncology Service, Birmingham, United Kingdom

Search for more papers by this author
Jon C. Luscombe

Jon C. Luscombe

* Consultant Orthopaedic Surgeon, The Wesley Hospital, Brisbane, Australia, † Consultant Orthopaedic Surgeon, The Edinburgh Royal Infirmary, Edinburgh, Scotland, ‡ Orthopaedic Registrar, § Consultant Musculoskeletal Pathologist, The Royal Orthopaedic Hospital and ¶Consultant Orthopaedic Oncologist, The Royal Orthopaedic Hospital Oncology Service, Birmingham, United Kingdom

Search for more papers by this author
D. Chas Mangham

D. Chas Mangham

* Consultant Orthopaedic Surgeon, The Wesley Hospital, Brisbane, Australia, † Consultant Orthopaedic Surgeon, The Edinburgh Royal Infirmary, Edinburgh, Scotland, ‡ Orthopaedic Registrar, § Consultant Musculoskeletal Pathologist, The Royal Orthopaedic Hospital and ¶Consultant Orthopaedic Oncologist, The Royal Orthopaedic Hospital Oncology Service, Birmingham, United Kingdom

Search for more papers by this author
Robert J. Grimer

Robert J. Grimer

* Consultant Orthopaedic Surgeon, The Wesley Hospital, Brisbane, Australia, † Consultant Orthopaedic Surgeon, The Edinburgh Royal Infirmary, Edinburgh, Scotland, ‡ Orthopaedic Registrar, § Consultant Musculoskeletal Pathologist, The Royal Orthopaedic Hospital and ¶Consultant Orthopaedic Oncologist, The Royal Orthopaedic Hospital Oncology Service, Birmingham, United Kingdom

Search for more papers by this author
First published: 02 September 2005
Citations: 61
Mr Robert J. Grimer, The Royal Orthopaedic Hospital Oncology Service, The Royal Orthopaedic Hospital, Bristol Road South, Northfield, Birmingham, UK B31 2AP.
Email: [email protected]

S. M. M. Sommerville FRACS (Orth); J. T. Patton FRCS (Tr and Orth); J. C. Luscombe MRCS; D. C. Mangham FRCPath; R. J. Grimer FRCS (Orth).

Abstract

Aim:  Controversy exists with regard to the nomenclature, treatment and outcome of a group of well-differentiated lipomatous tumours sometimes labelled as atypical lipomas. The purpose of the present paper is to attempt to clarify these controversies by reporting our experience with this lesion.

Methods:  The clinical features and follow up of 61 patients with the diagnosis of deep atypical lipoma and a minimum two-year follow up were examined.

Results:  All patients were treated by marginal excision alone. A local recurrence was seen in five patients (8%). Three recurred once and two recurred twice. No patient had a metastasis or died as a result of the tumour. No lesion dedifferentiated.

Conclusion:  We believe the term atypical lipoma is appropriate for these tumours, as they appear not to have any metastatic potential, merely a propensity to recur locally. The chance of dedifferentiation is small and radiotherapy may play a role in its causation. We suggest that a simple marginal resection (shelling-out) is adequate treatment for these lesions. Radiotherapy should not be used.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.